Integra LifeSciences (IART) vs SI-BONE (SIBN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
SI-BONE (SIBN) has outperformed Integra LifeSciences (IART) over the past year, gaining 24.0% versus a loss of 9.5%. Over five years, SIBN leads with a -17.5% price change compared with -80.2% for IART. Integra LifeSciences is the larger company by market cap ($1.05 billion vs $868.1 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IART | SIBN |
|---|---|---|
| Share price | $13.44 | $19.37 |
| Market cap | $1.05B | $868.14M |
| 1-day change | +0.22% | +2.70% |
| YTD return | +7.97% | -4.36% |
| 1-year return | -9.45% | +24.00% |
| 5-year return | -80.19% | -17.46% |
| Forward P/E | 5.17 | — |
| EPS (TTM) | $-0.09 | $-0.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $20.49 | $21.89 |
| 52-week low | $8.70 | $11.48 |
| Distance from 52-week high | -34.41% | -11.51% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +36.76% | +30.20% |
| Average volume | 916.55K | 543.48K |
| Shares outstanding | 77.77M | 44.82M |
| Employees | 4,427 | 376 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SIBN has outperformed IART by 33.5 percentage points over the past year.
About Integra LifeSciences
IART stock →Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments.
Health Care · Medical/Dental Instruments · 4,427 employees
About SI-BONE
SIBN stock →SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products.
Health Care · Medical/Dental Instruments · 376 employees
IART vs SIBN FAQ
Which is bigger, Integra LifeSciences or SI-BONE?
Integra LifeSciences (IART) is larger, with a market capitalization of $1.05B compared with $868.14M for SI-BONE (SIBN).
Which stock has performed better over the past year, IART or SIBN?
SIBN returned +24.00% over the past 12 months, compared with -9.45% for IART (price return, excluding dividends). Past performance does not predict future results.
Are Integra LifeSciences and SI-BONE in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.